WO2012161662A1 - Pore-spanning biomimetic membranes embedded with aquaporin - Google Patents
Pore-spanning biomimetic membranes embedded with aquaporin Download PDFInfo
- Publication number
- WO2012161662A1 WO2012161662A1 PCT/SG2012/000186 SG2012000186W WO2012161662A1 WO 2012161662 A1 WO2012161662 A1 WO 2012161662A1 SG 2012000186 W SG2012000186 W SG 2012000186W WO 2012161662 A1 WO2012161662 A1 WO 2012161662A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pmoxa
- membrane
- vesicles
- thin film
- pore
- Prior art date
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 128
- 230000003592 biomimetic effect Effects 0.000 title claims abstract description 35
- 108010063290 Aquaporins Proteins 0.000 title claims description 20
- 102000010637 Aquaporins Human genes 0.000 title claims description 19
- 239000000758 substrate Substances 0.000 claims abstract description 70
- 239000010409 thin film Substances 0.000 claims abstract description 27
- 229910052751 metal Inorganic materials 0.000 claims abstract description 24
- 239000002184 metal Substances 0.000 claims abstract description 24
- 239000011248 coating agent Substances 0.000 claims abstract description 22
- 238000000576 coating method Methods 0.000 claims abstract description 22
- 108091005703 transmembrane proteins Proteins 0.000 claims abstract description 12
- 102000035160 transmembrane proteins Human genes 0.000 claims abstract description 12
- 229920001400 block copolymer Polymers 0.000 claims description 42
- 238000000034 method Methods 0.000 claims description 26
- 239000011148 porous material Substances 0.000 claims description 26
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 25
- 229910052737 gold Inorganic materials 0.000 claims description 25
- 239000010931 gold Substances 0.000 claims description 25
- 229920001223 polyethylene glycol Polymers 0.000 claims description 25
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 23
- 239000002202 Polyethylene glycol Substances 0.000 claims description 21
- 239000004417 polycarbonate Substances 0.000 claims description 19
- 229920000515 polycarbonate Polymers 0.000 claims description 19
- -1 poly(2- methyloxazoline) Polymers 0.000 claims description 15
- 239000004971 Cross linker Substances 0.000 claims description 11
- 229920001577 copolymer Polymers 0.000 claims description 9
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 8
- 230000002209 hydrophobic effect Effects 0.000 claims description 8
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate group Chemical group C(C(=C)C)(=O)[O-] CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 6
- 238000004132 cross linking Methods 0.000 claims description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 6
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 5
- 238000005240 physical vapour deposition Methods 0.000 claims description 5
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims description 4
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 4
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 3
- 229910052763 palladium Inorganic materials 0.000 claims description 3
- 229910052697 platinum Inorganic materials 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 239000004332 silver Substances 0.000 claims description 3
- 230000004927 fusion Effects 0.000 claims description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- 230000035699 permeability Effects 0.000 description 22
- 238000007373 indentation Methods 0.000 description 16
- 150000002632 lipids Chemical class 0.000 description 16
- 230000004907 flux Effects 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 238000004630 atomic force microscopy Methods 0.000 description 13
- 238000009292 forward osmosis Methods 0.000 description 12
- 238000000149 argon plasma sintering Methods 0.000 description 9
- 230000035515 penetration Effects 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000003599 detergent Substances 0.000 description 7
- 238000010348 incorporation Methods 0.000 description 7
- 150000003904 phospholipids Chemical class 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000002356 single layer Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 238000000349 field-emission scanning electron micrograph Methods 0.000 description 5
- 239000010408 film Substances 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000003204 osmotic effect Effects 0.000 description 5
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- 238000005452 bending Methods 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 239000002502 liposome Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 239000013535 sea water Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- XOJVVFBFDXDTEG-UHFFFAOYSA-N Norphytane Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 3
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- NLEBIOOXCVAHBD-QKMCSOCLSA-N dodecyl beta-D-maltoside Chemical compound O[C@@H]1[C@@H](O)[C@H](OCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 NLEBIOOXCVAHBD-QKMCSOCLSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229960003151 mercaptamine Drugs 0.000 description 3
- 150000003141 primary amines Chemical class 0.000 description 3
- 108010030416 proteoliposomes Proteins 0.000 description 3
- 238000001338 self-assembly Methods 0.000 description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 description 3
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- PCLFEHAPITXKJL-UHFFFAOYSA-N 5,8-dihydroxy-2-[2-(4-methoxyphenyl)ethyl]chromen-4-one Chemical compound C1=CC(OC)=CC=C1CCC1=CC(=O)C2=C(O)C=CC(O)=C2O1 PCLFEHAPITXKJL-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
- 239000000232 Lipid Bilayer Substances 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000010612 desalination reaction Methods 0.000 description 2
- 230000009881 electrostatic interaction Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- RBQRWNWVPQDTJJ-UHFFFAOYSA-N methacryloyloxyethyl isocyanate Chemical compound CC(=C)C(=O)OCCN=C=O RBQRWNWVPQDTJJ-UHFFFAOYSA-N 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000006557 surface reaction Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 229920000428 triblock copolymer Polymers 0.000 description 2
- CITHEXJVPOWHKC-UUWRZZSWSA-N 1,2-di-O-myristoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC CITHEXJVPOWHKC-UUWRZZSWSA-N 0.000 description 1
- GODZNYBQGNSJJN-UHFFFAOYSA-N 1-aminoethane-1,2-diol Chemical compound NC(O)CO GODZNYBQGNSJJN-UHFFFAOYSA-N 0.000 description 1
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 description 1
- 108050005714 Aquaporin Z Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 238000000418 atomic force spectrum Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000149 chemical water pollutant Substances 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229920000359 diblock copolymer Polymers 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000445 field-emission scanning electron microscopy Methods 0.000 description 1
- 238000007499 fusion processing Methods 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- QYRFJLLXPINATB-UHFFFAOYSA-N hydron;2,4,5,6-tetrafluorobenzene-1,3-diamine;dichloride Chemical compound Cl.Cl.NC1=C(F)C(N)=C(F)C(F)=C1F QYRFJLLXPINATB-UHFFFAOYSA-N 0.000 description 1
- 230000002727 hyperosmolar Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000010842 industrial wastewater Substances 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920001178 poly(dimethylsiloxane)-block-poly(2-methyloxazoline) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920006289 polycarbonate film Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000003725 proteoliposome Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/14—Dynamic membranes
- B01D69/141—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes
- B01D69/142—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes with "carriers"
- B01D69/144—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes with "carriers" containing embedded or bound biomolecules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/002—Forward osmosis or direct osmosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/10—Supported membranes; Membrane supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/44—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
- C02F1/445—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis by forward osmosis
Definitions
- Biomimetic membranes demonstrate the greatest potential for improving forward osmosis performance, and it is estimated that biomimetic membranes can have a water permeability far superior to current state-of-the-art forward osmosis polymer membranes. However, such membranes can lack the mechanical strength and stability necessary in commercial applications.
- the performance of a biomimetic membrane is highly dependent on the integrity of the selective layer and the density of the water channel inside the membrane. Key hurdles in fabricating planar biomimetic membranes are (1) defect formation owing to the thin and fragile self-assembled bilayer; and (2) low coverage of the porous substrate because of weak interface interaction between the selective layer and the substrate.
- the structure has a porous substrate, a metal coating on the surface of the porous substrate, an intermediary layer on the surface of the metal coating, and a thin film having a transmembrane protein is incorporated therein.
- the thin film is layered on top of the intermediary layer and spans one or more pores of the substrate.
- the transmembrane protein can be an aquaporin, such as AqpZ.
- the porous substrate can be alumina, polycarbonate, or other polymeric membranes prepared from phase inversion, for example cellulose acetate or sulfonated polyethersulfone or polyacrylonitrile.
- the metal coating on the porous substrate can be gold, silver, platinum, palladium, or any combination thereof.
- the intermediary layer can be polyethylene glycol, can have methacrylate groups, or can be functionalized with a photoreactive crosslinker, such as the acrylic acid derivatives methylacrylic acid, ethyl acrylate, methyl methacrylate, or combinations thereof.
- the thin film can be l,2-dimyristoyl-5 «-glycero-3-phosphocholine (DMPC) or a block copolymer, such as poly(2-methyloxazoline)-6/ocA:-poly(dimethylsiloxane)-b/ocA:-poly(2- methyloxazoline), which is more commonly referred to as PMOXA-PDMS- PMOXA.
- the block copolymer can be PMOXA 12 -PDMS 54 -PMOXAi 2 .
- the block copolymer can be less than 20 nm thick.
- the block copolymer can have a molecular weight of the hydrophilic block from 500 to 2500 and a molecular weight of the hydrophobic block from 2500 to 10,000.
- the hydrophilic to hydrophobic weight ratio can be from 1 :4 to 2:3.
- the block copolymer can be PMOXA-PDMS-PMOXA (500-2500-500), PMOXA-PDMS-PMOXA (1000-4000-1000), PMOXA-PDMS- PMOXA (1300-5000-1300), PMOXA-PDMS-PMOXA (1600-5600-1600), or higher.
- FIGs 1(b) and 1(c) illustrate a schematic representation of a biomimetic membrane on a porous substrate.
- the biomimetic membrane is formed on a carboxylated polyethylene glycol (PEG) cushion chemisorbed on a gold layer that was deposited on a porous alumina.
- the biomimetic membrane is formed on a methacrylate cushion chemisorbed on a gold layer that was deposited on polycarbonate.
- Disclosed herein is a method for preparing a biomimetic membrane and its supporting substrate.
- the method includes incorporating a transmembrane protein into vesicles, such as by rehydrating a dry film of phospholipids or block copolymer in a suitable buffer and adding a solution containing the transmembrane protein in a detergent. After the detergent is removed, the vesicles are formed.
- multilamellar vesicle solution can then be extruded using a polycarbonate membrane to control the vesicle size.
- the vesicles are then fused onto the surface of a porous substrate having a metal coating and an intermediary layer.
- a thin layer of metal is coated on the substrate by physical vapor deposition.
- the intermediary layer can be chemisorbed onto the metal-coated substrate, for example by incubating the metal-coated substrate with a solution that forms the intermediary layer.
- the intermediary layer can be polyethylene glycol (PEG), preferably Carboxyl-PEG-SH.
- the substrate surface can be functionalized, such as by
- the vesicles are fused to the thin film by incubating them together or by crosslinking them together, such as by exposing them to UV light.
- the vesicles can be fused in the presence of a gentle vacuum from approximately 500 mbar to approximately 970 mbar.
- the intermediary layer can be crosslinked to the thin film in order to rupture the vesicles and obtain a pore- spanning membrane.
- Disclosed herein is a method of using the biomimetic membrane and supporting structure to perform osmosis.
- the structure is placed between two solutions of differing osmolarity.
- the methods disclosed herein can be used to form structures having improved mechanical properties. Without wishing to be bound to any particular theory, it is believed that by providing an intermediate layer, a greater number of transmembrane aquaporin channels can be incorporated into the thin film.
- the aquaporin extends slightly beyond the lipid bilayer because the hydrophilic portions are larger than the hydrophilic heads of lipids. Without an intermediate layer, the hydrophilic portions of the aquaporin directly contact the solid support. It is believed that the inclusion of an intermediate layer acts as a spacer to prevent the aquaporin channels from directly contacting the porous substrate.
- Figure 1(a) is a schematic representation of a biomimetic membrane formed directly on a porous alumina support.
- Figure 1(b) is a schematic representation of a biomimetic membrane formed on a carboxylated PEG cushion chemisorbed on a gold layer that was deposited on a porous alumina support.
- Figure 1(c) is a schematic representation of a biomimetic membrane formed on a methacrylate cushion chemisorbed on a gold layer that was deposited on a porous polycarbonate support.
- Figures 2(a) and 2(b) are graphs showing the kinetics of water permeability through vesicles in a stopped-flow apparatus.
- Figure 3 is a graph showing the effect of increasing AqpZ content on the permeability of DMPC vesicles.
- Figures 4(a) and 4(b) are Field Emission Scanning Electron Microscope (FESEM) images of empty alumina substrates (a) before gold coating and (b) after gold coating.
- FESEM Field Emission Scanning Electron Microscope
- Figures 4(c) and 4(d) are atomic force microscopy (AFM) images of empty substrate :(c) plain porous alumina, (d) porous alumina coated with a 60nm gold layer.
- AFM atomic force microscopy
- Figures 4(e) and 4(f) are atomic force microscopy (AFM) images of (e) the DMPC membrane of the design of Figure 1(a) and (f) the DPMC membrane of Figure 1(b).
- Figure 5 is a force indentation curve for a pore-spanning biomimetic membrane of Figure 1(a) prepared from DMPC-AqpZ vesicles having a lipid protein ratio (LPR) of 2000:1.
- AFM atomic force microscopy
- Figures 6(a) and 6(b) are histograms of (a) rupture forces and (b) indentation depths for the DMPC membrane in Figure 1(a).
- Figures 6(c) and 6(d) are histograms of (c) rupture forces and (d) indentation depths for the DMPC membrane in Figure 1(b).
- Figure 7(a) is an illustration of a scheme for preparing a pore-spanning membrane having an embedded aquaporin.
- Figure 7(b) is an illustration of a scheme for modifying the surface of an intermediary layer.
- Figure 7(c) is an illustration of a scheme for making an ultrathin pore- spanning membrane.
- Figure 8 is a graph showing the kinetics of water permeability through vesicles in a stopped-flow apparatus (The curve on the top is for AqpZ incorporated ABA block copolymer vesicles and the bottom one is for the control sample without AqpZ).
- Figure 9 is a graph showing the effect of increasing AqpZ content on the permeability of ABA block copolymers vesicles.
- Figure 10(a) is an FESEM image of a top surface view of an empty polycarbonate substrate before the formation of the planar pore-spanning biomimetic membrane.
- Figure 10(b) is an FESEM image of a cross-sectional view of an empty polycarbonate substrate before the formation of the planar pore-spanning biomimetic membrane.
- Figure 10(c) is an FESEM image of a top surface view of a polycarbonate substrate after the formation of the planar pore-spanning biomimetic membrane.
- Figure 10(d) is an FESEM image of a cross-sectional view of apolycarbonate substrate after the formation of the planar pore-spanning biomimetic membrane.
- Figure 1 1 is a schematic illustrating a static test of forward osmosis performance using a biomimetic membrane (pressure retarded osmosis (PRO) mode).
- PRO pressure retarded osmosis
- Figure 12 is a graph showing the effect of AqpZ content and draw solution concentration on forward osmosis water flux.
- Figure 13 is a graph showing the effect of AqpZ content on forward osmosis water flux in sea water desalination.
- the membrane structure and support can be prepared as follows.
- the membrane is prepared on, and spans across, a porous substrate.
- porous substrates that can be used are alumina, track-etched polycarbonate film and polymeric membranes, such as cellulose acetate.
- the substrates are fully porous, have a smooth surface, and have a pure water permeability greater than 1000 L/m h/bar.
- the substrates have auniform pore size and do not have torturous pores.
- the pore size of the substrate can be between about 20 run and about 100 nm.
- a metal layer is coated onto the surface of the substrate by, for example, physical vapor deposition.
- the metal can be gold, silver, platinum, palladium, or any combination thereof.
- the thickness of the metal coating on the surface can be in the range of about 40 nm to about 60 nm.
- the thickness of the metal coating can be optimized according to the pore size to avoid the pore narrowing effect. For example, a gold coating of about 50 nm is recommended for a membrane support having a 50 nm pore size.
- the metal coated substrate is modified by adding an intermediary layer.
- the intermediate layer can be chemisorbed onto the metal coated porous substrate.
- An example of an intermediary layer is carboxylated polyethylene glycol (PEG), which can be incubated on the metal coated porous substrate so that the PEG molecules can be chemisorbed by self-assembly of thiol groups.
- PEG polyethylene glycol
- the bifunctional-PEG polymer cushion significantly enhances the flexibility of thin film on the substrate and gives rise to higher atomic force microscopy (AFM) breakthrough forces when Aquaporin Z is reconstituted into the pore-suspending membrane on the bifunctional-PEG coated substrate.
- AFM atomic force microscopy
- the PEG polymer cushion has the advantages of acting as a spacer between the membrane and the porous substrate and is believed to preserve the functional structure of the aquaporin.
- an optimal ratio of AqpZ to lipid or block copolymer is needed to achieve the highest forward osmosis (FO) performance.
- the optimal molar ratio of AqpZ to lipid or block copolymer is 1 : 100.
- the block copolymer can have a molecular weight of the hydrophilic block from 500 to 2500 and a molecular weight of the hydrophobic block from 2500 to 10,000.
- the hydrophilic to hydrophobic weight ratio can be from 1 :4 to 2:3.
- the block copolymer can be PMOXA-PDMS-PMOXA (500-2500- 500), PMOXA-PDMS-PMOXA (1000-4000-1000), PMOXA-PDMS-PMOXA (1300-5000-1300), PMOXA-PDMS-PMOXA (1600-5600-1600), or higher.
- the ABA block copolymer can be PMOXA-PDMS-PMOXA (1000- 4000-1000).
- the intermediary layer can be functionalized with photoreactive crosslinkers. Any combination of chemicals that can functionalize the surface with photoreactive bonds can be applied.
- photoreactive crosslinkers include, but are not limited to, acrylic acid derivatives.
- acrylic acid derivatives include, but are not limited to, methacrylic acid, ethyl acrylate, methyl methacrylate, and combinations thereof.
- cystamine di hydrochloride, glutathione, thiol-polyethylene glycol- amine, peptides and proteins with thiol ends can be used.
- the first monolayer is not necessarily the primary amine monolayer.
- the first monolayer can be the carboxylated-monolayer.
- Chemicals such as 3- mercaptopropionic acid, lipoic acid, glutathione, thiol- polyethylene glycol- carboxyl, peptides and proteins with thiol ends can be applied for the first layer, in which case chemicals such as amine-polyethylene glycol-methacrylate, 2- isocyanatoethylmethacrylate will be needed in the sequential modification.
- the first method is preferred because only a few combinations of conjugating chemicals are required.
- Surface modification is also not limited to layer-by-layer modification.
- the surface can be modified directly by acryloyl chloride or 2-isocyanatoethylmethacrylate so that a thin layer of photoreactive crosslinker can be constructed.
- the transmembrane water channel protein is incorporated into the thin film that will span across the pores of the substrate.
- the transmembrane water channel protein can be an aquaporin.
- the aquaporin can be AqpZ, which is derived from E. coli.
- the thin film can be phospholipids or block copolymers.
- Phospholipid or block copolymers having a hydrophilic to hydrophobic weight ratio from about 1 :4 to about 2:3 and an unsaturated bond at the hydrophilic end can embed the transmembrane water channel protein and form the planar pore-spanning membrane.
- the phospholipid or block copolymer can be less than 20 nm thick.
- the thin film can be a lipid bilayer, a single block copolymer, a mixture of different block copolymers, or a mixture of block copolymers and lipid.
- the thin film can preferably be dissolved in a detergent solution and form vesicles at neutral pH.
- Lipids particularly phospholipids, having a phase transition temperature lower than 37 °C can incorporate AqpZ.
- a preferred phospholipid is a 1 ,2- dimyristoyl-SH-glycero-3-phosphocholine (DMPC).
- the block copolymer can be a diblock copolymer or a triblock copolymer, such as an ABA triblock copolymer.
- the thin film is a UV- polymerizable block copolymer.
- a preferred block copolymer is poly(2- methyloxazoline)-block-poly(dimethylsiloxane)-block-poly(2-methyloxazoline), which is abbreviated as PMOXA-PDMS-PMOXA.
- the block copolymer can be PMOXA 12 -PDMS 54 -PMOXA 12 . More preferably, the block copolymer is less than 20 nra thick.
- the block copolymer can be approximately 20% to approximately 25% hydrophilic (by molecular weight), with the remainder hydrophobic.
- the block copolymers can carry photoreactive crosslinkable functional groups at the hydrophilic ends, such as the acrylic acid derivatives previously described.
- the transmembrane protein can be incorporated into the thin film by rehydrating the lipid or block copolymer and then mixing in a solution containing the transmembrane protein and detergent.
- the protein is reconstituted into the bilayer, and the detergent can be removed by dialysis or with biobeads.
- the vesicles are extruded with a polycarbonate membrane to control the vesicle size.
- the pore size of polycarbonate membrane is larger than the pore diameter of the porous substrate
- the vesicles are then fused onto the prepared substrate, which can be done by incubating the vesicles with the porous substrate.
- a gentle vacuum can be applied to aid the fusion process.
- the vacuum can be approximately 500 mbar to approximately 970 mbar.
- the mixture can be gently stirred.
- the vesicles are ruptured to obtain pore-spanning flat membranes.
- the vesicle can be ruptured by osmotic shock or strong interfacial interaction.
- the membrane and the porous substrate contain photoreactive crosslinkable functional groups, the vesicles can be ruptured by UV crosslinking polymerization. Crosslinking also stabilizes the overall membrane structure.
- the UV polymerization is carried out below 37 °C under argon protection.
- the ruptured vesicles can be spread to obtain the pore suspending membrane.
- the membranes thus prepared according to the methods described above can be used in water treatment applications, such as reverse osmosis and forward osmosis.
- Example 1 Preparation of a biomimetic membrane suspended by a PEG cushion
- Example 1 illustrates the detailed preparation and characterization of a biomimetic membrane suspended by a PEG cushion.
- Example 1.1 AqpZ incorporation and membrane permeability measurement Aquaporin was inserted into lipid vesicles to investigate the compatibility of aquaporin and lipids.
- the lipid used was 1 ,2-dimyristoyl- sn- glycero-3-phosphocholine (DMPC).
- DMPC 1,2-dimyristoyl- sn- glycero-3-phosphocholine
- the vesicle suspension was prepared by the film rehydration method.
- the dry film of DMPC was rehydrated in lx PBS buffer.
- the multilamellar vesicles solution was extruded using a polycarbonate membrane to control the vesicle size.
- DDM dodecyl-P-d-maltoside
- the permeability of the liposome and the proteoliposome was determined using the stop-flow method. Vesicles were rapidly mixed with a hyperosmolar sucrose buffer, which causes water to permeate from the vesicle to an environmental solution and results in vesicle shrinkage. The vesicle size changes were detected by light scattering recorded at an emission wavelength of 577 nm in a stop-flow apparatus. The measuring temperature was 25 °C. As vesicles shrink, light scattering increases.
- S is the vesicle surface area (m 2 )
- V 0 is the initial volume of vesicles (m 3 )
- V w is the partial molar volume of water (0.018L/mol)
- a osm is the osmolarity difference that drives the shrinkage of vesicles (osmol/L)
- Pf is the osmotic water permeability, in m/s.
- Liposomes and proteoliposomes were rapidly mixed with a 600 mosmol/1 sucrose solution as described in Borgnia et. al. Journal of Molecular Biology 1999; 291 : 1169-1 179.
- Figure 2 is a graph showing the kinetics of water permeability through vesicles in a stopped-flow apparatus. The data was normalized to between 0 and 1. The solid lines represent the exponential fitting curves.
- Figure 2(a) shows an increase in the relative light scattering signals with and without AqpZ incorporated into the DMPC vesicles at a protein to lipid molar ratio of 1 :2000. The initial time rise for AqpZ-DMPC vesicles was between 20 and 30 ms, whereas the DMPC vesicles needed 2.5 s to reach equilibrium.
- Example 1.2 Pore-suspending membrane preparation
- FIG. 1(a) and 1(b) Two configurations were designed as illustrated in Figures 1(a) and 1(b).
- vesicles were ruptured directly on a porous alumina substrate (Synkera Technologies, Inc., Longmont, Colorado, USA) by the interfacial interactions method. Without wishing to be bound by any particular theory, it is believed that vesicles are ruptured because they have electrostatic interactions with the alumina support.
- the alumina substrate was modified by physical vapor deposition of 40-60 nm layer of gold.
- Carboxyl- PEG-SH (lmg/ml ethanol solution) (JenKem Technology USA Inc., Allen, Texas, USA) was incubated on the gold-coated porous alumina for more than 24 hours so that the PEG molecules were chemisorbed on gold by self-assembly of thiol groups.
- Liposomes and proteoliposomes were incubated with the porous alumina directly above the phase transition temperature of phospholipids for 2-8 h.
- the vesicles were ruptured on the PEG polymer cushion by the Interfacial interactions method. Without wishing to be bound by any particular theory, it is believed that vesicles are ruptured because they have electrostatic interactions with the carboxyl groups on the PEG cushion.
- Figure 4(a) and 4(b) are Field Emission Scanning Electron Microscope (FESEM) images of empty alumina substrates (a) before gold coating and (b) after gold coating.
- the pore diameters before and after gold coating are estimated to be 80 ⁇ 10 nm and 90 ⁇ 10 nm, respectively.
- Figures 4(c) and 4(d) are atomic force microscopy (AFM) images of empty substrate (c) plain porous alumina, (d) porous alumina coated with a 60nm gold layer.
- Figures 4(c) and (d) show the hexagonal structure obtained by AFM and the pore-to-pore distance remained at about 170 ⁇ 10nm before and after gold coating.
- the theoretical maximal penetration depth (h dep th) which was dependent on both the tip geometry (i.e., the radius of the tip, R t i p ) and the pore topology (i.e., the radius of the pore, R por e), was about 125nm according to this equation as used by Steltenkamp et. al. Biophysics Journal 2006; 91 : 217-226.
- the experiments showed that the penetration depth observed in the profile in Figure 4 was 45 ⁇ 15 nm lor the empty substrate and it was reduced to 4U ⁇ 10 nm after the gold coating.
- Figures 4(e) and 4(f) are atomic force microscopy (AFM) images of (e) the DMPC membrane of the design of Figure 1(a) and (f) the DPMC membrane of Figure 1(b).
- AFM atomic force microscopy
- DMPC liposomes had fused and formed the pore-spanning membrane on top of the porous alumina.
- Example 1.3 Force indentation measurements of pore-suspending membrane The local mechanical properties of the membranes were tested by conducting force indentation experiments in the center of the unsupported membrane-covered pores with a constant piezo-electric velocity of 0.5 ⁇ s "1 at a temperature of 20 ⁇ 1 °C. The force curve was recorded for more than 150 times at different pores.
- the force indentation measurements were performed in the center of the pore-suspending membrane in order to obtain the elastic response of the membrane.
- Figure 5 is a force indentation curve for a pore-spanning biomimetic membrane of Figure 1(a) prepared from DMPC-AqpZ vesicles having a protein to lipid ratio of 1 :2000. After the initial contact between the tip and the membrane, the membrane was indented until it ruptured. Hard-wall repulsions were visible in some cases when the tip hits the pore walls at the maximal indentation depth.
- Figures 6(a) and 6(b) are histograms of (a) rupture forces and (b) indentation depths for the DMPC membrane in Figure 1(a).
- Figures 6(c) and 6(d) are
- the membrane suspended on a substrate having carboxylated-PEG coating layer i.e., the membrane of Figure 1(b)
- a substrate having carboxylated-PEG coating layer i.e., the membrane of Figure 1(b)
- the membrane of Figure 1(b) shows a greater penetration depth.
- the membrane dilatation during AFM indentation could be estimated by adopting the geometry of a hemisphere to imitate the surface morphology of the indented membrane.
- the significant difference in penetration depths of the two designs implies that the lipid layer might flow from the edge into the pores upon indentation due to the soft PEG polymer cushion of the membrane of Figure 1(b), which increases the flexibility between the membrane and the substrate.
- Example 1.5 Effect of AqpZ on the local mechanical stability of membranes Upon indentation, a normal force was applied on the pore-suspending membrane. If the membrane was fixed on the substrate, there would be an increase in the lateral tension.
- the two-dimensional (2D) Young's modulus might be applicable to describe the lateral tension within the membrane between AqpZ and DMPC, as the maximum strains produced from these interactions can be represented by the Young's modulus:
- the E 2D can only be obtained only when the membrane is relatively fixed on the pore upon indentation.
- Table 1 lists the rupture forces and penetration depths of membranes having different surface functionalization and AzpZ concentration.
- Example 2 Preparation of a biomimetic membrane suspended by a thin layer of methacrylate cushion
- Example 2 illustrates the detailed preparation and characterization of a biomimetic membrane suspended by a thin layer of methacrylate cushion, as shown in Figure 1(c).
- FIG. 7(a) is an illustration of a scheme for preparing a pore-spanning membrane having an embedded aquaporin.
- the surface of the porous substrate was modified with a photoreactive crosslinker.
- a gold coated porous polycarbonate membrane was modified by physical vapor deposition of a 40-60 nm layer of gold.
- the gold-coated polycarbonate membrane was incubated with cysteamine solution (0.1-1.0 mg/ml in PBS solution) for more than 12 hours at 4°C so that a thin layer of cysteamine was chemisorbed on the gold by self-assembly of thiol groups.
- the modified polycarbonate membrane was then further activated by N-Hydroxysuccinimide / 1 -ethyl 3-(3-dimethylaminopropyl) carbodiimide (NHS/EDC) and the resulting membrane was further immersed in acrylic acid (2-10% wt) PBS solution for more than 12 hours at 4°C.
- acrylic acid 2-10% wt
- Example 2.2 AqpZ incorporation into ABA block copolymer vesicles
- AzpZ was incorporated into a thin film of the block-copolymer PMOXA 12 - PDMS 54 -PMOXAi 2 (molecular weight 6000).
- the vesicle suspension was prepared by the film rehydration method.
- the dry film of PMOXAi 2 -PDMS 54 -PMOXAi 2 was rehydrated in lx PBS buffer.
- An AQPz solution of 1 mg/ml in 9 mM dodecyl- ⁇ - d-maltoside (DDM) was added during the formation of the block copolymer vesicles, and the mixture was stirred until a homogeneous mixture was formed.
- DDM dodecyl- ⁇ - d-maltoside
- Figure 7(c) is an illustration of a scheme for making an ultrathin pore- spanning membrane.
- the modified polycarbonate membrane was immobilized by using an alumina tap on a ceramic funnel with a porous support on the top.
- the proteopolymersome solution was purged with argon slowly for 10 minutes and was dropped onto the surface of the polycarbonate membrane support upon application of a vacuum of approximately 920 mbar. Gentle stirring was performed for 10 minutes.
- the 2-D crosslinking of AqpZ and amphiphlic material was performed by UV irradiation on the membrane complex for 15 minutes at 4°C.
- Example 2.4 AqpZ incorporation and membrane permeability measurement
- the water-permeability of the PMOXA 12 -PDMS 54 -PMOXA 12 membranes with and without AqpZ incorporated therein was measured similarly to Example 1.1.
- the shrinkage of the vesicle size with and without AqpZ was detected by light scattering and recorded at an emission wavelength of 577 nm in the stop-flow apparatus.
- the measuring temperature was 25°C. As vesicles shrink, light scattering increases, and thus an increase in the signal corresponds to a reduction in vesicle size.
- Figure 8 is a graph showing the kinetics of water permeability through vesicles in a stopped-flow apparatus, and it shows the increase in relative light scattering signals with and without incorporation of AqpZ into the ABA block copolymer membrane at 25°C.
- the initial time rise for AqpZ- ABA vesicles was between 0 and 20 ms, whereas no obvious size change was found for the pristine ABA block copolymer vesicles although the size variation was recorded for 10s.
- the calculated permeability of AqpZ -ABA copolymer (molar ratio: 1 :200) vesicles was 2.59x l0 m/s.
- the incorporation of AqpZ led to a great improvement in the permeability of the membrane, demonstrating the reconstitution of AqpZ into the ABA block copolymer vesicles with a correct configuration.
- AqpZ was then reconstituted at different protein polymer ratios as shown in Figure 9.
- the observed permeability increased remarkably as the ratio of AqpZ to ABA copolymer increased from 1 :400 to 1 :300 and then reached a plateau between a ratio of 1:200 to 1 :50.
- one possible explanation for this phenomenon might be due to the decreasing efficiency of incorporating AqpZ.
- Example 2.5 Morphology of the planar pore-spanning biomimetic membranes The surface morphology and cross section of the membrane was observed by Field Emission Scanning Electron Microscopy (FESEM). Figures 10(a) and (b) showed visible pores on the substrate before polymerization. Figure 10(a) is a top- surface view, and Figure 10(b) is a cross-sectional view. Figures 10(c) and (d) showed that the pores on the top-surface were completely covered after
- Figure 10(c) is a top-surface view
- Figure 10(d) is a cross- sectional view.
- the contrast of the pore-spanning membrane and the substrate was quite similar as the pore-spanning membrane less than 10 nm thick.
- the pore- spanning membrane is transparent and thin ( Figure 10(c)), but it is difficult to estimate the thickness from the FESEM image.
- Example 2.6 Performance of the planar pore-spanning biomimetic membranes
- the membrane with a diameter of 3 mm was placed between the two chambers as shown Figure 1 1.
- a conductivity meter was inserted in the feed chamber to monitor the salt reverse flux. Water levels of both chambers were raised simultaneously and slowly. The water permeation through the pore-spanning biomimetic membrane was analyzed by the weight increase of the draw solution side.
- FIG. 12 is a graph showing the effect of AqpZ content and draw solution concentration on forward osmosis water flux.
- the water flux of each membrane increased almost proportionally as the concentration of NaCl in the draw solution chamber increased.
- Table 2 shows the salt reverse flux of each test in
- Table 2 Salt reverse flux of the membranes prepared using different AqpZ- ABA ratio in the forward osmosis test (PRO mode).
- Example 2.7 Forward osmosis performance by using seawater as feed
- the PMOXA-PDMS-PMOXA copolymer of Example 2 can be used with the PEG intermediary layer of Example 1
- the DMPC thin film of Example 1 can be used with the intermediary layer of Example 1 (chemisorption of cysteamine, activated by NHS/EDC, and immersed in acrylic acid PBS solution).
- the alumina substrate of Example 1 can be used with the block copolymer thin film of Example 2
- the polycarbonate substrate of Example 2 can be used with the DMPC thin film of Example 1.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
Disclosed herein is a biomimetic membrane and its supporting substrate. The structure has a porous substrate, a metal coating on the surface of the porous substrate, an intermediary layer on the surface of the metal coating, and a thin film having a transmembrane protein is incorporated therein. Also disclosed is a method of making the membrane.
Description
PORE-SPANNING BIOMIMETIC MEMBRANES
EMBEDDED WITH AQUAPORIN
RELATED APPLICATION
This application claims the benefit of Singapore Provisional Application No. 201 103837-9, filed on May 26, 2011. The entire teachings of the above application are incorporated herein by reference.
BACKGROUND OF THE INVENTION
Forward osmosis (FO) has shown great potential in many water treatment applications, such as industrial waste water treatment, landfill leachate
concentration, liquid food concentration, and wastewater reclamation in space. As the osmotic pressure is the only driving force in the forward osmosis process, high water permeability and water selectivity are the two most important criteria for choosing membrane materials.
Biomimetic membranes demonstrate the greatest potential for improving forward osmosis performance, and it is estimated that biomimetic membranes can have a water permeability far superior to current state-of-the-art forward osmosis polymer membranes. However, such membranes can lack the mechanical strength and stability necessary in commercial applications. The performance of a biomimetic membrane is highly dependent on the integrity of the selective layer and the density of the water channel inside the membrane. Key hurdles in fabricating planar biomimetic membranes are (1) defect formation owing to the thin and fragile self-assembled bilayer; and (2) low coverage of the porous substrate because of weak interface interaction between the selective layer and the substrate.
Thus, there is a need to incorporate aquaporin into a matrix with a desired configuration that permits water to pass through and to assemble ultrathin
biomimetic membranes into useful forms with improved mechanic strength and stability.
SUMMARY OF THE INVENTION
Disclosed herein is a biomimetic membrane and its supporting substrate. The structure has a porous substrate, a metal coating on the surface of the porous substrate, an intermediary layer on the surface of the metal coating, and a thin film having a transmembrane protein is incorporated therein. The thin film is layered on top of the intermediary layer and spans one or more pores of the substrate. The transmembrane protein can be an aquaporin, such as AqpZ. The porous substrate can be alumina, polycarbonate, or other polymeric membranes prepared from phase inversion, for example cellulose acetate or sulfonated polyethersulfone or polyacrylonitrile. The metal coating on the porous substrate can be gold, silver, platinum, palladium, or any combination thereof. The intermediary layer can be polyethylene glycol, can have methacrylate groups, or can be functionalized with a photoreactive crosslinker, such as the acrylic acid derivatives methylacrylic acid, ethyl acrylate, methyl methacrylate, or combinations thereof. The thin film can be l,2-dimyristoyl-5«-glycero-3-phosphocholine (DMPC) or a block copolymer, such as poly(2-methyloxazoline)-6/ocA:-poly(dimethylsiloxane)-b/ocA:-poly(2- methyloxazoline), which is more commonly referred to as PMOXA-PDMS- PMOXA. The block copolymer can be PMOXA12-PDMS54-PMOXAi2. The block copolymer can be less than 20 nm thick. The block copolymer can have a molecular weight of the hydrophilic block from 500 to 2500 and a molecular weight of the hydrophobic block from 2500 to 10,000. The hydrophilic to hydrophobic weight ratio can be from 1 :4 to 2:3. The block copolymer can be PMOXA-PDMS-PMOXA (500-2500-500), PMOXA-PDMS-PMOXA (1000-4000-1000), PMOXA-PDMS- PMOXA (1300-5000-1300), PMOXA-PDMS-PMOXA (1600-5600-1600), or higher.
Figures 1(b) and 1(c) illustrate a schematic representation of a biomimetic membrane on a porous substrate. In Figure 1 (b), the biomimetic membrane is formed on a carboxylated polyethylene glycol (PEG) cushion chemisorbed on a gold layer that was deposited on a porous alumina. In Figure 1(c), the biomimetic membrane is formed on a methacrylate cushion chemisorbed on a gold layer that was deposited on polycarbonate.
Disclosed herein is a method for preparing a biomimetic membrane and its supporting substrate. The method includes incorporating a transmembrane protein into vesicles, such as by rehydrating a dry film of phospholipids or block copolymer in a suitable buffer and adding a solution containing the transmembrane protein in a detergent. After the detergent is removed, the vesicles are formed. The
multilamellar vesicle solution can then be extruded using a polycarbonate membrane to control the vesicle size. The vesicles are then fused onto the surface of a porous substrate having a metal coating and an intermediary layer.
To produce a metal-coated substrate, a thin layer of metal is coated on the substrate by physical vapor deposition. The intermediary layer can be chemisorbed onto the metal-coated substrate, for example by incubating the metal-coated substrate with a solution that forms the intermediary layer. The intermediary layer can be polyethylene glycol (PEG), preferably Carboxyl-PEG-SH. Alternatively, or in combination, the substrate surface can be functionalized, such as by
chemisorption of an intermediary layer having a photoreactive crosslinker.
The vesicles are fused to the thin film by incubating them together or by crosslinking them together, such as by exposing them to UV light. Optionally, the vesicles can be fused in the presence of a gentle vacuum from approximately 500 mbar to approximately 970 mbar. Optionally, the intermediary layer can be crosslinked to the thin film in order to rupture the vesicles and obtain a pore- spanning membrane.
Disclosed herein is a method of using the biomimetic membrane and supporting structure to perform osmosis. The structure is placed between two solutions of differing osmolarity.
The methods disclosed herein can be used to form structures having improved mechanical properties. Without wishing to be bound to any particular theory, it is believed that by providing an intermediate layer, a greater number of transmembrane aquaporin channels can be incorporated into the thin film. The aquaporin extends slightly beyond the lipid bilayer because the hydrophilic portions are larger than the hydrophilic heads of lipids. Without an intermediate layer, the hydrophilic portions of the aquaporin directly contact the solid support. It is
believed that the inclusion of an intermediate layer acts as a spacer to prevent the aquaporin channels from directly contacting the porous substrate.
BRIEF DESCRIPTION OF THE DRAWINGS
The foregoing will be apparent from the following more particular description of example embodiments of the invention, as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating embodiments of the present invention.
Figure 1(a) is a schematic representation of a biomimetic membrane formed directly on a porous alumina support.
Figure 1(b) is a schematic representation of a biomimetic membrane formed on a carboxylated PEG cushion chemisorbed on a gold layer that was deposited on a porous alumina support.
Figure 1(c) is a schematic representation of a biomimetic membrane formed on a methacrylate cushion chemisorbed on a gold layer that was deposited on a porous polycarbonate support.
Figures 2(a) and 2(b) are graphs showing the kinetics of water permeability through vesicles in a stopped-flow apparatus.
Figure 3 is a graph showing the effect of increasing AqpZ content on the permeability of DMPC vesicles.
Figures 4(a) and 4(b) are Field Emission Scanning Electron Microscope (FESEM) images of empty alumina substrates (a) before gold coating and (b) after gold coating.
Figures 4(c) and 4(d) are atomic force microscopy (AFM) images of empty substrate :(c) plain porous alumina, (d) porous alumina coated with a 60nm gold layer.
Figures 4(e) and 4(f) are atomic force microscopy (AFM) images of (e) the DMPC membrane of the design of Figure 1(a) and (f) the DPMC membrane of Figure 1(b).
Figure 5 is a force indentation curve for a pore-spanning biomimetic membrane of Figure 1(a) prepared from DMPC-AqpZ vesicles having a lipid protein ratio (LPR) of 2000:1.
Figures 6(a) and 6(b) are histograms of (a) rupture forces and (b) indentation depths for the DMPC membrane in Figure 1(a).
Figures 6(c) and 6(d) are histograms of (c) rupture forces and (d) indentation depths for the DMPC membrane in Figure 1(b).
Figure 7(a) is an illustration of a scheme for preparing a pore-spanning membrane having an embedded aquaporin.
Figure 7(b) is an illustration of a scheme for modifying the surface of an intermediary layer.
Figure 7(c) is an illustration of a scheme for making an ultrathin pore- spanning membrane.
Figure 8 is a graph showing the kinetics of water permeability through vesicles in a stopped-flow apparatus (The curve on the top is for AqpZ incorporated ABA block copolymer vesicles and the bottom one is for the control sample without AqpZ).
Figure 9 is a graph showing the effect of increasing AqpZ content on the permeability of ABA block copolymers vesicles.
Figure 10(a) is an FESEM image of a top surface view of an empty polycarbonate substrate before the formation of the planar pore-spanning biomimetic membrane.
Figure 10(b) is an FESEM image of a cross-sectional view of an empty polycarbonate substrate before the formation of the planar pore-spanning biomimetic membrane.
Figure 10(c) is an FESEM image of a top surface view of a polycarbonate substrate after the formation of the planar pore-spanning biomimetic membrane.
Figure 10(d) is an FESEM image of a cross-sectional view of apolycarbonate substrate after the formation of the planar pore-spanning biomimetic membrane.
Figure 1 1 is a schematic illustrating a static test of forward osmosis performance using a biomimetic membrane (pressure retarded osmosis (PRO) mode).
Figure 12 is a graph showing the effect of AqpZ content and draw solution concentration on forward osmosis water flux.
Figure 13 is a graph showing the effect of AqpZ content on forward osmosis water flux in sea water desalination.
DETAILED DESCRIPTION OF THE INVENTION
The membrane structure and support can be prepared as follows. The membrane is prepared on, and spans across, a porous substrate. Examples of porous substrates that can be used are alumina, track-etched polycarbonate film and polymeric membranes, such as cellulose acetate. In preferred embodiments, the substrates are fully porous, have a smooth surface, and have a pure water permeability greater than 1000 L/m h/bar. Preferably, the substrates have auniform pore size and do not have torturous pores. The pore size of the substrate can be between about 20 run and about 100 nm.
Substrate surface preparation
A metal layer is coated onto the surface of the substrate by, for example, physical vapor deposition. The metal can be gold, silver, platinum, palladium, or any combination thereof. The thickness of the metal coating on the surface can be in the range of about 40 nm to about 60 nm. Preferably, the thickness of the metal coating can be optimized according to the pore size to avoid the pore narrowing effect. For example, a gold coating of about 50 nm is recommended for a membrane support having a 50 nm pore size.
Next, the metal coated substrate is modified by adding an intermediary layer. The intermediate layer can be chemisorbed onto the metal coated porous substrate. An example of an intermediary layer is carboxylated polyethylene glycol (PEG), which can be incubated on the metal coated porous substrate so that the PEG
molecules can be chemisorbed by self-assembly of thiol groups. As described more fully with respect to Example 1, the bifunctional-PEG polymer cushion significantly enhances the flexibility of thin film on the substrate and gives rise to higher atomic force microscopy (AFM) breakthrough forces when Aquaporin Z is reconstituted into the pore-suspending membrane on the bifunctional-PEG coated substrate. The PEG polymer cushion has the advantages of acting as a spacer between the membrane and the porous substrate and is believed to preserve the functional structure of the aquaporin. Although the local membrane mechanical stability can be further improved by increasing the AqpZ content, an optimal ratio of AqpZ to lipid or block copolymer is needed to achieve the highest forward osmosis (FO) performance. In some instances, the optimal molar ratio of AqpZ to lipid or block copolymer is 1 : 100. The block copolymer can have a molecular weight of the hydrophilic block from 500 to 2500 and a molecular weight of the hydrophobic block from 2500 to 10,000. The hydrophilic to hydrophobic weight ratio can be from 1 :4 to 2:3. The block copolymer can be PMOXA-PDMS-PMOXA (500-2500- 500), PMOXA-PDMS-PMOXA (1000-4000-1000), PMOXA-PDMS-PMOXA (1300-5000-1300), PMOXA-PDMS-PMOXA (1600-5600-1600), or higher. In some instances, the ABA block copolymer can be PMOXA-PDMS-PMOXA (1000- 4000-1000).
Optionally, the intermediary layer can be functionalized with photoreactive crosslinkers. Any combination of chemicals that can functionalize the surface with photoreactive bonds can be applied. Examples of photoreactive crosslinkers include, but are not limited to, acrylic acid derivatives. Exemplary acrylic acid derivatives include, but are not limited to, methacrylic acid, ethyl acrylate, methyl methacrylate, and combinations thereof. Specifically, for grafting the primary amine monolayer, cystamine di hydrochloride, glutathione, thiol-polyethylene glycol- amine, peptides and proteins with thiol ends can be used. To conjugate the primary amine monolayer with methacrylate chemicals in the water phase, methacrylic acid, butyl acrylate, carboxyl- polyethylene glycol-methacrylate can be used. For conjugation occurring in the oil phase, methacrylate chemicals, such as acryloyl chloride, can be used.
Altematively, the layer-by-layer modification can be reversed. The first monolayer is not necessarily the primary amine monolayer. For example, the first monolayer can be the carboxylated-monolayer. Chemicals such as 3- mercaptopropionic acid, lipoic acid, glutathione, thiol- polyethylene glycol- carboxyl, peptides and proteins with thiol ends can be applied for the first layer, in which case chemicals such as amine-polyethylene glycol-methacrylate, 2- isocyanatoethylmethacrylate will be needed in the sequential modification. The first method is preferred because only a few combinations of conjugating chemicals are required.
Surface modification is also not limited to layer-by-layer modification. For example, when the substrate is porous alumina, the surface can be modified directly by acryloyl chloride or 2-isocyanatoethylmethacrylate so that a thin layer of photoreactive crosslinker can be constructed.
Thin film preparation
The transmembrane water channel protein is incorporated into the thin film that will span across the pores of the substrate. The transmembrane water channel protein can be an aquaporin. Preferably, the aquaporin can be AqpZ, which is derived from E. coli.
The thin film can be phospholipids or block copolymers. Phospholipid or block copolymers having a hydrophilic to hydrophobic weight ratio from about 1 :4 to about 2:3 and an unsaturated bond at the hydrophilic end can embed the transmembrane water channel protein and form the planar pore-spanning membrane. The phospholipid or block copolymer can be less than 20 nm thick. The thin film can be a lipid bilayer, a single block copolymer, a mixture of different block copolymers, or a mixture of block copolymers and lipid. The thin film can preferably be dissolved in a detergent solution and form vesicles at neutral pH.
Lipids, particularly phospholipids, having a phase transition temperature lower than 37 °C can incorporate AqpZ. A preferred phospholipid is a 1 ,2- dimyristoyl-SH-glycero-3-phosphocholine (DMPC).
The block copolymer can be a diblock copolymer or a triblock copolymer, such as an ABA triblock copolymer. Preferably, the thin film is a UV- polymerizable block copolymer. A preferred block copolymer is poly(2- methyloxazoline)-block-poly(dimethylsiloxane)-block-poly(2-methyloxazoline), which is abbreviated as PMOXA-PDMS-PMOXA. More preferably, the block copolymer can be PMOXA12-PDMS54-PMOXA12. More preferably, the block copolymer is less than 20 nra thick. The block copolymer can be approximately 20% to approximately 25% hydrophilic (by molecular weight), with the remainder hydrophobic. The block copolymers can carry photoreactive crosslinkable functional groups at the hydrophilic ends, such as the acrylic acid derivatives previously described.
The transmembrane protein can be incorporated into the thin film by rehydrating the lipid or block copolymer and then mixing in a solution containing the transmembrane protein and detergent. The protein is reconstituted into the bilayer, and the detergent can be removed by dialysis or with biobeads. The vesicles are extruded with a polycarbonate membrane to control the vesicle size. Preferably, the pore size of polycarbonate membrane is larger than the pore diameter of the porous substrate
The vesicles are then fused onto the prepared substrate, which can be done by incubating the vesicles with the porous substrate. Optionally, a gentle vacuum can be applied to aid the fusion process. For example, the vacuum can be approximately 500 mbar to approximately 970 mbar. Optionally, the mixture can be gently stirred. After fusion, the vesicles are ruptured to obtain pore-spanning flat membranes. The vesicle can be ruptured by osmotic shock or strong interfacial interaction. Alternatively, if the membrane and the porous substrate contain photoreactive crosslinkable functional groups, the vesicles can be ruptured by UV crosslinking polymerization. Crosslinking also stabilizes the overall membrane structure. Preferably, the UV polymerization is carried out below 37 °C under argon protection. Optionally, the ruptured vesicles can be spread to obtain the pore suspending membrane.
The membranes thus prepared according to the methods described above can be used in water treatment applications, such as reverse osmosis and forward osmosis.
The following specific examples illustrate the disclosure herein, and are not intended to limit the scope of the invention. The teachings of all publications cited herein are incorporated by reference in their entirety.
Example 1: Preparation of a biomimetic membrane suspended by a PEG cushion
Example 1 illustrates the detailed preparation and characterization of a biomimetic membrane suspended by a PEG cushion.
Example 1.1 AqpZ incorporation and membrane permeability measurement Aquaporin was inserted into lipid vesicles to investigate the compatibility of aquaporin and lipids. In this example, the lipid used was 1 ,2-dimyristoyl- sn- glycero-3-phosphocholine (DMPC). The vesicle suspension was prepared by the film rehydration method. The dry film of DMPC was rehydrated in lx PBS buffer. The multilamellar vesicles solution was extruded using a polycarbonate membrane to control the vesicle size. For reconstitution experiments, lmg/ml in 9 mM dodecyl-P-d-maltoside (DDM) was added during the formation of lipid vesicles and the mixture was stirred until the vesicles were formed. Then, the detergent was removed with biobeads. The proteoliposomes were then extruded.
The permeability of the liposome and the proteoliposome was determined using the stop-flow method. Vesicles were rapidly mixed with a hyperosmolar sucrose buffer, which causes water to permeate from the vesicle to an environmental solution and results in vesicle shrinkage. The vesicle size changes were detected by light scattering recorded at an emission wavelength of 577 nm in a stop-flow apparatus. The measuring temperature was 25 °C. As vesicles shrink, light scattering increases. Thus, an increase in the signal corresponds to a reduction in vesicle size, whichh can be fitted to an exponential rise equation as follows:
Y= A exp(-t) (1) where Y is the intensity of signal, t is the recording time (seconds), A is a constant, and k is the initial rate constant (s"1). The osmotic water permeability can be calculated from Equation (2):
Pf = (2)
' (S/VQ VwAosm ' . where S is the vesicle surface area (m2), V0 is the initial volume of vesicles (m3), Vw is the partial molar volume of water (0.018L/mol), Aosm is the osmolarity difference that drives the shrinkage of vesicles (osmol/L), and Pf is the osmotic water permeability, in m/s.
Liposomes and proteoliposomes were rapidly mixed with a 600 mosmol/1 sucrose solution as described in Borgnia et. al. Journal of Molecular Biology 1999; 291 : 1169-1 179.
The initial rise of the light scattering signal was fitted by using Equation (1) and the permeability was determined from Equation (2). Figure 2 is a graph showing the kinetics of water permeability through vesicles in a stopped-flow apparatus. The data was normalized to between 0 and 1. The solid lines represent the exponential fitting curves. Figure 2(a) shows an increase in the relative light scattering signals with and without AqpZ incorporated into the DMPC vesicles at a protein to lipid molar ratio of 1 :2000. The initial time rise for AqpZ-DMPC vesicles was between 20 and 30 ms, whereas the DMPC vesicles needed 2.5 s to reach equilibrium. The calculated permeabilities of DMPC and AqpZ-DMPC vesicles are 8.33 x 10" and 252 cm/s, respectively. Figure 2(b) is a graph showing the rise in light scattering between 0 and 10 s for the DMPC vesicles.
The incorporation of AqpZ led to a 3000-fold greater permeability compared to the pristine DMPC vesicles, thus demonstrating the reconstitution of AqpZ into the DMPC vesicles with a functional configuration. AqpZ was then reconstituted at different protein to lipid molar ratios as shown in Figure 3. The observed
permeability increased remarkably and was then followed by a sharp decrease while the protein-lipid molar ratio varied from 1 :6000, 1 :4000, 1 :2000 to 1 : 1000.
Example 1.2: Pore-suspending membrane preparation
Two configurations were designed as illustrated in Figures 1(a) and 1(b). In the design of Figure 1(a), vesicles were ruptured directly on a porous alumina substrate (Synkera Technologies, Inc., Longmont, Colorado, USA) by the interfacial interactions method. Without wishing to be bound by any particular theory, it is believed that vesicles are ruptured because they have electrostatic interactions with the alumina support. In the design of Figure 1(b), the alumina substrate was modified by physical vapor deposition of 40-60 nm layer of gold. Then, Carboxyl- PEG-SH (lmg/ml ethanol solution) (JenKem Technology USA Inc., Allen, Texas, USA) was incubated on the gold-coated porous alumina for more than 24 hours so that the PEG molecules were chemisorbed on gold by self-assembly of thiol groups. Liposomes and proteoliposomes were incubated with the porous alumina directly above the phase transition temperature of phospholipids for 2-8 h. Finally, the vesicles were ruptured on the PEG polymer cushion by the Interfacial interactions method. Without wishing to be bound by any particular theory, it is believed that vesicles are ruptured because they have electrostatic interactions with the carboxyl groups on the PEG cushion.
Figure 4(a) and 4(b) are Field Emission Scanning Electron Microscope (FESEM) images of empty alumina substrates (a) before gold coating and (b) after gold coating. The pore diameters before and after gold coating are estimated to be 80±10 nm and 90±10 nm, respectively.
Figures 4(c) and 4(d) are atomic force microscopy (AFM) images of empty substrate (c) plain porous alumina, (d) porous alumina coated with a 60nm gold layer. Figures 4(c) and (d) show the hexagonal structure obtained by AFM and the pore-to-pore distance remained at about 170±10nm before and after gold coating. The theoretical maximal penetration depth (hdepth), which was dependent on both the tip geometry (i.e., the radius of the tip, Rtip) and the pore topology (i.e., the radius of the pore, Rpore), was about 125nm according to this equation
as used by Steltenkamp et. al. Biophysics Journal 2006; 91 : 217-226. In practice, the experiments showed that the penetration depth observed in the profile in Figure 4
was 45±15 nm lor the empty substrate and it was reduced to 4U±10 nm after the gold coating.
Figures 4(e) and 4(f) are atomic force microscopy (AFM) images of (e) the DMPC membrane of the design of Figure 1(a) and (f) the DPMC membrane of Figure 1(b). One can easily identify membrane-covered and -uncovered pores from the height profiles of these two designs in Figures 4(e) and 4(f). A comparison of penetration depth between Figures 4(c) and (e) as well as Figures 4(d) and (f) show that there was a 70% drop in penetration depth (/'. e. , from 45±15 nm to 15±5 nm, and from 40±10 nm to 15±5 nm, respectively), revealing that DMPC liposomes had fused and formed the pore-spanning membrane on top of the porous alumina.
Example 1.3: Force indentation measurements of pore-suspending membrane The local mechanical properties of the membranes were tested by conducting force indentation experiments in the center of the unsupported membrane-covered pores with a constant piezo-electric velocity of 0.5 μηι s"1 at a temperature of 20±1 °C. The force curve was recorded for more than 150 times at different pores.
The force indentation measurements were performed in the center of the pore-suspending membrane in order to obtain the elastic response of the membrane.
Figure 5 is a force indentation curve for a pore-spanning biomimetic membrane of Figure 1(a) prepared from DMPC-AqpZ vesicles having a protein to lipid ratio of 1 :2000. After the initial contact between the tip and the membrane, the membrane was indented until it ruptured. Hard-wall repulsions were visible in some cases when the tip hits the pore walls at the maximal indentation depth.
Example 1.4: Effect of Carboxylated-PEG on the local mechanical stabilities of membranes
Figures 6(a) and 6(b) are histograms of (a) rupture forces and (b) indentation depths for the DMPC membrane in Figure 1(a). Figures 6(c) and 6(d) are
histograms of (c) rupture forces and (d) indentation depths for the DMPC membrane in Figure 1(b).
Comparing Figures 6(a) and 6(c), the membrane of Figure 1(b) shows a narrower rupture force distribution. Thus, the PEG polymer layer was able to smoothen the rough alumina surface with its soft polymer chains. In other words, the PEG polymer layer could ease packing of lipids, effectively dissipating indentation stresses and improving the membrane stability. The membrane suspended on a substrate having carboxylated-PEG coating layer (i.e., the membrane of Figure 1(b)) exhibited an average breakthrough force of 2.3±2.1 nN, which is relatively comparable to the average breakthrough force of 3.7±2.0 nN for the membrane suspended directly on porous alumina substrate (i.e. , the membrane of Figure 1(a)).
Comparing Figures 6(b) and 6(d), the membrane of Figure 1(b) shows a greater penetration depth. The membrane dilatation during AFM indentation could be estimated by adopting the geometry of a hemisphere to imitate the surface morphology of the indented membrane. The significant difference in penetration depths of the two designs implies that the lipid layer might flow from the edge into the pores upon indentation due to the soft PEG polymer cushion of the membrane of Figure 1(b), which increases the flexibility between the membrane and the substrate.
Example 1.5: Effect of AqpZ on the local mechanical stability of membranes Upon indentation, a normal force was applied on the pore-suspending membrane. If the membrane was fixed on the substrate, there would be an increase in the lateral tension. The two-dimensional (2D) Young's modulus might be applicable to describe the lateral tension within the membrane between AqpZ and DMPC, as the maximum strains produced from these interactions can be represented by the Young's modulus:
where F is the rupture force (nN), E2D is the Young's modulus (N/m), h is the penetration depth (nm), and r is the hole radius (nm). The bending rigidity of the membrane can be estimated as ~0.1E2Dd , where d is the bilayer thickness of 4.5 nm, as described in Goncalves et. al. Nature Methods 2006; 3: 1007-1012.
Table 1 : Local mechanical properties of membrane upon AFM indentation
The E2D can only be obtained only when the membrane is relatively fixed on the pore upon indentation.
Table 1 lists the rupture forces and penetration depths of membranes having different surface functionalization and AzpZ concentration. After incorporating AqpZ, the average breakthrough force increased when compared to the DMPC layer that did include AqpZ. Even at a very high lipid-to-protein ratio (LPR=6000), the increase of the average breakthrough forces was visible. As the LPR ratio decreased from 6000 to 1000, the breakthrough force increased drastically from 3.7 to 12.0 nN. Meanwhile, the penetration depth also decreased, indicating that the membrane became less flexible on the top of the PEG polymer cushion. The bending rigidity of the DMPC-AqpZ (LPR 2000:1) membrane (~59kBT) was larger than the bending modulus of a pristine DMPC bilayer (~13 keT). As the LPR value decreases to 1000 : 1 , the bending rigidity increased to ~ 160keT, indicating that the AqpZ molecules might respond to mechanical stresses less actively than DMPC molecules. Hence, the incorporation of AqpZ improved the energy barrier required for membrane rupture.
Example 2: Preparation of a biomimetic membrane suspended by a thin layer of methacrylate cushion
Example 2 illustrates the detailed preparation and characterization of a biomimetic membrane suspended by a thin layer of methacrylate cushion, as shown in Figure 1(c).
Example 2.1 : Substrate surface functionalization with photoreactive crosslinker Figure 7(a) is an illustration of a scheme for preparing a pore-spanning membrane having an embedded aquaporin. First, the surface of the porous substrate was modified with a photoreactive crosslinker. As shown in Figure 7(b), a gold coated porous polycarbonate membrane was modified by physical vapor deposition of a 40-60 nm layer of gold. Then, the gold-coated polycarbonate membrane was incubated with cysteamine solution (0.1-1.0 mg/ml in PBS solution) for more than 12 hours at 4°C so that a thin layer of cysteamine was chemisorbed on the gold by self-assembly of thiol groups. The modified polycarbonate membrane was then further activated by N-Hydroxysuccinimide / 1 -ethyl 3-(3-dimethylaminopropyl) carbodiimide (NHS/EDC) and the resulting membrane was further immersed in acrylic acid (2-10% wt) PBS solution for more than 12 hours at 4°C. The membrane substrate was washed thoroughly before use.
Example 2.2: AqpZ incorporation into ABA block copolymer vesicles AzpZ was incorporated into a thin film of the block-copolymer PMOXA12- PDMS54-PMOXAi2 (molecular weight 6000). The vesicle suspension was prepared by the film rehydration method. The dry film of PMOXAi2-PDMS54-PMOXAi2 was rehydrated in lx PBS buffer. An AQPz solution of 1 mg/ml in 9 mM dodecyl-β- d-maltoside (DDM) was added during the formation of the block copolymer vesicles, and the mixture was stirred until a homogeneous mixture was formed. The detergent was removed by using biobeads. The proteopolymersomes solution was then extruded using a polycarbonate track-etch membrane to control the vesicle size. The pore diameter of the polycarbonate membrane in this study was 50 nm. The resultant concentration of proteopolymersome was 0.5-10 mg/ml.
Example 2.3: Preparation of planar pore-spanning biomimetic membranes through
2-D UV crosslinking
Figure 7(c) is an illustration of a scheme for making an ultrathin pore- spanning membrane. The modified polycarbonate membrane was immobilized by using an alumina tap on a ceramic funnel with a porous support on the top. The proteopolymersome solution was purged with argon slowly for 10 minutes and was dropped onto the surface of the polycarbonate membrane support upon application of a vacuum of approximately 920 mbar. Gentle stirring was performed for 10 minutes. The 2-D crosslinking of AqpZ and amphiphlic material was performed by UV irradiation on the membrane complex for 15 minutes at 4°C.
Example 2.4: AqpZ incorporation and membrane permeability measurement The water-permeability of the PMOXA12-PDMS54-PMOXA12 membranes with and without AqpZ incorporated therein was measured similarly to Example 1.1. Vesicles were rapidly mixed with a 1M NaCl solution (osmolar pressure = 2 osmolar/L), which causes water to permeate from the vesicle and simultaneously results in vesicle shrinkage. The shrinkage of the vesicle size with and without AqpZ was detected by light scattering and recorded at an emission wavelength of 577 nm in the stop-flow apparatus. The measuring temperature was 25°C. As vesicles shrink, light scattering increases, and thus an increase in the signal corresponds to a reduction in vesicle size.
The initial rise of the light scattering signal was fitted by using Equation (1) and the permeability was determined from Equation (2). Figure 8 is a graph showing the kinetics of water permeability through vesicles in a stopped-flow apparatus, and it shows the increase in relative light scattering signals with and without incorporation of AqpZ into the ABA block copolymer membrane at 25°C. The initial time rise for AqpZ- ABA vesicles was between 0 and 20 ms, whereas no obvious size change was found for the pristine ABA block copolymer vesicles although the size variation was recorded for 10s. The calculated permeability of AqpZ -ABA copolymer (molar ratio: 1 :200) vesicles was 2.59x l0 m/s. The
incorporation of AqpZ led to a great improvement in the permeability of the membrane, demonstrating the reconstitution of AqpZ into the ABA block copolymer vesicles with a correct configuration.
AqpZ was then reconstituted at different protein polymer ratios as shown in Figure 9. The observed permeability increased remarkably as the ratio of AqpZ to ABA copolymer increased from 1 :400 to 1 :300 and then reached a plateau between a ratio of 1:200 to 1 :50. Without wishing to be bound by any particular theory, one possible explanation for this phenomenon might be due to the decreasing efficiency of incorporating AqpZ.
Example 2.5: Morphology of the planar pore-spanning biomimetic membranes The surface morphology and cross section of the membrane was observed by Field Emission Scanning Electron Microscopy (FESEM). Figures 10(a) and (b) showed visible pores on the substrate before polymerization. Figure 10(a) is a top- surface view, and Figure 10(b) is a cross-sectional view. Figures 10(c) and (d) showed that the pores on the top-surface were completely covered after
polymerization. Figure 10(c) is a top-surface view, and Figure 10(d) is a cross- sectional view. The contrast of the pore-spanning membrane and the substrate was quite similar as the pore-spanning membrane less than 10 nm thick. The pore- spanning membrane is transparent and thin (Figure 10(c)), but it is difficult to estimate the thickness from the FESEM image.
Example 2.6: Performance of the planar pore-spanning biomimetic membranes The membrane with a diameter of 3 mm was placed between the two chambers as shown Figure 1 1. A conductivity meter was inserted in the feed chamber to monitor the salt reverse flux. Water levels of both chambers were raised simultaneously and slowly. The water permeation through the pore-spanning biomimetic membrane was analyzed by the weight increase of the draw solution side.
The water flux of each membrane prepared from different AqpZ- ABA copolymer ratios was tested using ultrapure water as the feed and NaCl solution as
the draw solution. Figure 12 is a graph showing the effect of AqpZ content and draw solution concentration on forward osmosis water flux. The water flux of each membrane increased almost proportionally as the concentration of NaCl in the draw solution chamber increased. Table 2 shows the salt reverse flux of each test in
Figure 12. Almost all the salt reverse fluxes were below 10 g/m2/h.
Table 2: Salt reverse flux of the membranes prepared using different AqpZ- ABA ratio in the forward osmosis test (PRO mode).
Salt leakage (g/m2/h)
Concentration of
drawn solution AqpZ-ABA AqpZ-ABA AqpZ-ABA AqpZ-ABA
(M NaCl) (1 :100) (1 :200) (1 :300) (1 :400)
, 2.0 6.2±2.6 10.0±2.0 0.48±0.4 3.7±4.6
1.5 7.8±1.1 8.6±0.6 0.6±0.6 2.9±1.6
1.0 6.5±0.2 7.1±1.4 0.3±0.02 2.5±0.8
0.5 5.4±0.2 4.3±1.7 0.7±0.4 0.7±0.5
Additionally, as the ratio of AqpZ-ABA copolymer increased, the water flux also increased, which proved that the AqpZ molecules were embedded in the ABA block copolymer in a functional configuration when the vesicles were transformed to a planar membrane, as demonstrated by high water flux (see Example 2.7) and low reverse salt flux (Table 2).
Example 2.7: Forward osmosis performance by using seawater as feed
The water flux of each membrane prepared from different AqpZ-ABA copolymer ratios was tested using sea water (NaCl 3.5%) as the feed and 2M NaCl solution as the draw solution. The water flux of each membrane significantly increased as the ratio of AqpZ-ABA copolymer increased, as shown in Figure 13.
The net driving force was equivalent to the osmotic pressure of 1.4M NaCl to pure water, but the flux of the sea water test fell to 35-45%, likely due to the internal and external concentration polarization. Thus, the data simulates the performance of the membrane for water desalination.
Other Embodiments
All of the features disclosed in this specification may be combined in any combination. For example, and without limitation, the PMOXA-PDMS-PMOXA copolymer of Example 2 can be used with the PEG intermediary layer of Example 1 , and the DMPC thin film of Example 1 can be used with the intermediary layer of Example 1 (chemisorption of cysteamine, activated by NHS/EDC, and immersed in acrylic acid PBS solution). Similarly, the alumina substrate of Example 1 can be used with the block copolymer thin film of Example 2, and the polycarbonate substrate of Example 2 can be used with the DMPC thin film of Example 1. Each feature disclosed in this specification may be replaced by an alternative feature serving the same, equivalent, or similar purpose. Thus, unless expressly stated otherwise, each feature disclosed is only an example of a generic series of equivalent or similar features.
From the above description, one skilled in the art can easily ascertain the essential characteristics of the present invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions. Thus, other examples are also within the claims.
While this invention has been particularly shown and described with references to example embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.
Claims
1. A pore-spanning biomimetic membrane structure, comprising:
a porous substrate;
a metal coating on the surface of the porous support;
an intermediary layer on the surface of the metal coating; and
a thin film having a transmembrane protein incorporated therein;
wherein the thin film is layered on top of the intermediary layer and spans one or more pores of the substrate.
2. The structure of claim 1, wherein the transmembrane protein is an aquaporin.
3. The structure of claim 2, where the aquaporin is AqpZ.
The structure of claim 1 , wherein the porous substrate is alumina.
The structure of claim 1, wherein the porous substrate is polycarbonate.
The structure of claim 1 , wherein the metal coating is selected from the group consisting of gold, silver, platinum, palladium, and combinations thereof.
7. The structure of claim 1, wherein the metal coating is gold.
8. The structure of claim 1, wherein the intermediary layer is polyethylene glycol.
9. The structure of claim 1, wherein the intermediary layer has methacrylate groups.
10. The structure of claim 1, wherein the intermediary layer is functionalized with photoreactive crosslinkers.
11. The structure of claim 10, wherein the photoreactive crosslinkers are acrylic acid derivatives.
12. The structure of claim 1 1 , wherein the acrylic acid derivatives are
methylacrylic acid, ethyl acrylate, methyl methacrylate, or combinations thereof.
13. The structure of claim 1, wherein the thin film comprises 1 ,2-dimyristoyl-src- glycero-3 -phosphocholine.
14. The structure of claim 1, wherein the thin film comprises a block copolymer.
15. The structure of claim 14, wherein the block copolymer is poly(2- methyloxazoline)-&/ c^-poly(dimethylsiloxane)-b/ocA:-poly(2-methyloxazoline).
16. The structure of claim 15, wherein the block copolymer is PMOXA12- PDMS54-PMOXA12.
The structure of claim 15, wherein the block copolymer is less than 20
18. The structure of claim 15, wherein the molecular weight of the hydrophilic block of the block copolymer is from 500 to 2500 and the molecular weight of the hydrophobic block of the block copolymer is from 2500 to 10,000.
19. The structure of claim 15, wherein the hydrophilic to hydrophobic weight ratio of the block copolymer can be from 1 :4 to 2:3.
20. The structure of claim 15, wherein the copolymer is PMOXA-PDMS- PMOXA (500-2500-500), PMOXA-PDMS-PMOXA (1000-4000-1000), PMOXA- PDMS-PMOXA (1300-5000-1300), or PMOXA-PDMS-PMOXA (1600-5600- 1600).
21. The structure of claim 15, wherein the copolymer is PMOXA-PDMS- PMOXA (1000-4000-1000).
22. A method for preparing a pore-spanning biomimetic membrane structure, comprising:
incorporating a transmembrane protein into a thin film;
extruding the thin film with the incorporated transmembrane protein into vesicles; and
fusing the vesicle on a porous substrate having a metal coating and an intermediary layer.
23. The method of claim 22, wherein the transmembrane protein is incorporated into the thin film during rehydration of the thin film.
24. The method of claim 22, wherein vesicle fusion is performed in the presence of a vacuum.
25. The method of claim 24, wherein the vacuum is approximately 500 mbar to approximately 970 mbar.
26. The method of claim 22, further comprising incubating the vesicles with the porous substrate to fuse the vesicles to the intermediary layer.
27. The method of Claim 22, further comprising crosslinking the vesicles and the intermediary layer.
28. The method of Claim 22, further comprising exposing the vesicles and the substrate to UV irradiation.
29. The method of Claim 22, further comprising chemisorbing the intermediary layer onto the metal-coated substrate.
30. The method of Claim 22, further comprising forming the metal coating on the porous substrate by physical vapor deposition.
31. The method of Claim 22, further comprising functionalizing the intermediate layer with photoreactive crosslinkers.
32. The method of Claim 31 , wherein the photoreactive crosslinkers are acrylic acid derivatives.
33. The method of Claim 32, wherein the acrylic acid derivatives are
methylacrylic acid, ethyl acrylate, methyl methacrylate, or combinations thereof.
34. A method for performing osmosis, comprising:
placing the pore-spanning biomimetic membrane structure of claim 1 between two solutions of differing osmolarity.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG201103837 | 2011-05-26 | ||
SG201103837-9 | 2011-05-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012161662A1 true WO2012161662A1 (en) | 2012-11-29 |
Family
ID=47217519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SG2012/000186 WO2012161662A1 (en) | 2011-05-26 | 2012-05-25 | Pore-spanning biomimetic membranes embedded with aquaporin |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012161662A1 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014063097A1 (en) | 2012-10-19 | 2014-04-24 | Danisco Us Inc. | Stabilization of biomimetic membranes |
KR101752960B1 (en) | 2015-02-11 | 2017-07-19 | 한국기계연구원 | Liquid Filtration Structure Based on Artificial Membrane with Funcitonal Groups |
US9943812B2 (en) * | 2015-02-11 | 2018-04-17 | Inha-Industry Partnership Institute | Artificial membrane-fixed liquid filtration structure |
CN109070015A (en) * | 2016-03-16 | 2018-12-21 | 弗劳恩霍弗应用研究促进协会 | Porous membrane, preparation method and possible application |
CN109513040A (en) * | 2018-09-06 | 2019-03-26 | 天津大学 | The modified golden material of a kind of polyethylene glycol and anticoagulant peptides surface and preparation method |
US20190184344A1 (en) * | 2013-02-25 | 2019-06-20 | Aquaporin A/S | Systems for water extraction |
CN111068519A (en) * | 2019-12-17 | 2020-04-28 | 深圳大学 | Forward osmosis membrane and preparation method thereof |
WO2021066773A1 (en) * | 2019-10-02 | 2021-04-08 | Istanbul Teknik Universitesi | Aquaporin z integrated membrane production method |
CN112831395A (en) * | 2019-11-25 | 2021-05-25 | 深圳华大生命科学研究院 | Cell-like membranes for nanopore sequencing |
CN117384486A (en) * | 2023-02-10 | 2024-01-12 | 北京普译生物科技有限公司 | Mixed bionic membrane and preparation method and application thereof |
WO2024055284A1 (en) * | 2022-09-16 | 2024-03-21 | 深圳华大生命科学研究院 | Ion cross-linked biomimetic membrane, preparation method therefor, and use thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040049230A1 (en) * | 2002-07-29 | 2004-03-11 | Mt Technologies, Inc. | Biomimetic membranes |
US20040149688A1 (en) * | 2002-09-24 | 2004-08-05 | Commissariat A L'energie Atomique | Method for producing a biomimetic membrane, biomimetic membrane and its applications |
WO2007033675A1 (en) * | 2005-09-20 | 2007-03-29 | Aquaporin Aps | Biomimetic water membrane comprising aquaporins used in the production of salinity power |
NZ542286A (en) * | 2005-09-07 | 2008-04-30 | Agres Ltd | A method of forming biomimetic membranes |
CN101301583A (en) * | 2002-07-29 | 2008-11-12 | Mt技术股份有限公司 | Biomimetic membranes |
WO2010040353A2 (en) * | 2008-10-07 | 2010-04-15 | Danfoss Aquaz A/S | Biomimetic membrane formed from a vesicle-thread conjugate |
US20110084026A1 (en) * | 2009-06-30 | 2011-04-14 | B.G. Negev Technologies Ltd. | Biomimetic membranes, their production and uses thereof in water purification |
-
2012
- 2012-05-25 WO PCT/SG2012/000186 patent/WO2012161662A1/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040049230A1 (en) * | 2002-07-29 | 2004-03-11 | Mt Technologies, Inc. | Biomimetic membranes |
CN101301583A (en) * | 2002-07-29 | 2008-11-12 | Mt技术股份有限公司 | Biomimetic membranes |
US20040149688A1 (en) * | 2002-09-24 | 2004-08-05 | Commissariat A L'energie Atomique | Method for producing a biomimetic membrane, biomimetic membrane and its applications |
NZ542286A (en) * | 2005-09-07 | 2008-04-30 | Agres Ltd | A method of forming biomimetic membranes |
WO2007033675A1 (en) * | 2005-09-20 | 2007-03-29 | Aquaporin Aps | Biomimetic water membrane comprising aquaporins used in the production of salinity power |
WO2010040353A2 (en) * | 2008-10-07 | 2010-04-15 | Danfoss Aquaz A/S | Biomimetic membrane formed from a vesicle-thread conjugate |
US20110084026A1 (en) * | 2009-06-30 | 2011-04-14 | B.G. Negev Technologies Ltd. | Biomimetic membranes, their production and uses thereof in water purification |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014063097A1 (en) | 2012-10-19 | 2014-04-24 | Danisco Us Inc. | Stabilization of biomimetic membranes |
US20190184344A1 (en) * | 2013-02-25 | 2019-06-20 | Aquaporin A/S | Systems for water extraction |
US11813579B2 (en) * | 2013-02-25 | 2023-11-14 | Aquaporin A/S | Systems for water extraction for up-concentration of organic solutes |
KR101752960B1 (en) | 2015-02-11 | 2017-07-19 | 한국기계연구원 | Liquid Filtration Structure Based on Artificial Membrane with Funcitonal Groups |
US9943812B2 (en) * | 2015-02-11 | 2018-04-17 | Inha-Industry Partnership Institute | Artificial membrane-fixed liquid filtration structure |
CN109070015A (en) * | 2016-03-16 | 2018-12-21 | 弗劳恩霍弗应用研究促进协会 | Porous membrane, preparation method and possible application |
CN109513040A (en) * | 2018-09-06 | 2019-03-26 | 天津大学 | The modified golden material of a kind of polyethylene glycol and anticoagulant peptides surface and preparation method |
WO2021066773A1 (en) * | 2019-10-02 | 2021-04-08 | Istanbul Teknik Universitesi | Aquaporin z integrated membrane production method |
US11931699B2 (en) | 2019-10-02 | 2024-03-19 | Istanbul Teknik Universitesi | Aquaporin Z integrated membrane production method |
CN112831395B (en) * | 2019-11-25 | 2024-01-16 | 深圳华大生命科学研究院 | Cell membrane-like membranes for nanopore sequencing |
CN112831395A (en) * | 2019-11-25 | 2021-05-25 | 深圳华大生命科学研究院 | Cell-like membranes for nanopore sequencing |
CN111068519A (en) * | 2019-12-17 | 2020-04-28 | 深圳大学 | Forward osmosis membrane and preparation method thereof |
CN111068519B (en) * | 2019-12-17 | 2022-04-15 | 深圳大学 | Forward osmosis membrane and preparation method thereof |
WO2024055284A1 (en) * | 2022-09-16 | 2024-03-21 | 深圳华大生命科学研究院 | Ion cross-linked biomimetic membrane, preparation method therefor, and use thereof |
CN117384486A (en) * | 2023-02-10 | 2024-01-12 | 北京普译生物科技有限公司 | Mixed bionic membrane and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012161662A1 (en) | Pore-spanning biomimetic membranes embedded with aquaporin | |
Wang et al. | Preparation and characterization of pore-suspending biomimetic membranes embedded with Aquaporin Z on carboxylated polyethylene glycol polymer cushion | |
Sun et al. | Stabilization and immobilization of aquaporin reconstituted lipid vesicles for water purification | |
EP2758156B1 (en) | Aquaporin based thin film composite membranes | |
JP7072509B2 (en) | Self-assembled nanostructures and separation membranes containing aquaporin water channels, and methods of using them | |
JP5654493B2 (en) | Nanofabricated membranes using polymerized proteoliposomes | |
Xie et al. | An aquaporin-based vesicle-embedded polymeric membrane for low energy water filtration | |
Tang et al. | Biomimetic aquaporin membranes coming of age | |
Li et al. | Preparation of supported lipid membranes for aquaporin Z incorporation | |
Li et al. | Deformation and poration of lipid bilayer membranes by cationic nanoparticles | |
Sun et al. | Highly permeable aquaporin-embedded biomimetic membranes featuring a magnetic-aided approach | |
CN108136330B (en) | Bionic membrane | |
Górecki et al. | Improved reverse osmosis thin film composite biomimetic membranes by incorporation of polymersomes | |
KR20190079670A (en) | Self-assembling polymer vesicle structure with functional molecules | |
Kaufmann et al. | A detailed investigation of the formation kinetics and layer structure of poly (ethylene glycol) tether supported lipid bilayers | |
Shao et al. | Polyelectrolyte multilayer-cushioned fluid lipid bilayers: a parachute model | |
Azarafza et al. | Aquaporin‐Based Biomimetic Membranes for Low Energy Water Desalination and Separation Applications | |
CN110430937B (en) | Diblock copolymer vesicles and separation membranes comprising aquaporin water channels and methods of making and using the same | |
Purkait et al. | Biologically responsive membranes | |
Yu et al. | Theoretical and experimental research of polyelectrolyte multilayer membrane prepared by layer by layer self-assembly | |
Schuster et al. | Biomimetic S-layer supported lipid membranes | |
Grzelakowski et al. | Terminal groups control self-assembly of amphiphilic block copolymers in solution | |
Ronen et al. | Formation of pore-spanning lipid membrane and cross-membrane water and ion transport | |
Schuster | Biomimetic design of nanopatterned membranes | |
Joshi et al. | Low Fouling Polyelectrolyte Layer-by-Layer Self-Assembled Membrane for High Performance Dye/Salt Fractionation: Sequence Effect of Self-Assembly |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12790053 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12790053 Country of ref document: EP Kind code of ref document: A1 |